Free for Members Oct. 5: Novel CAR T-Cell Therapies for Hematologic Malignancies

ASGCT'S Insight Series is a new virtual series designed to provide attendees with the latest research and insights on a variety of cutting-edge topics presented by leading gene and cell therapy experts. This fall the series is back with free-for-members sessions Oct. 5 and 19. 

October 5: Novel CAR T-Cell Therapies for Hematologic Malignancies

Moderators: Daniela Bischof, PhD and Justin Eyquem, PhD
Indiana University School of Medicine, University of California, San Francisco

Lessons Learned on CAR T-Cells for Malignancies

Cliona Rooney, PhD
Texas Children's Hospital / Baylor College of Medicine

Novel CRISPR/Cas-Based Editing Approaches for Studying T-Cell Function

Julia Carnevale, MD
University of California San Francisco

Novel CRISPR/Cas Based Editing Approaches for Generating Engineered T Cells

Beau Webber, PhD
University of Minnesota

This session will provide:

• a review of the current state of CAR-T cell therapies

• updates on how CRISPR-based genome editing technologies are being applied 

Register Now

Oct. 19: Delivery to Skeletal Muscles: Breaking through Barriers for Genetic Medicine

Moderators: Christina Pacak, PhD and Eduard Ayuso, DVM, PhD
University of Minnesota, DiNAQOR AG

Gene Therapy Approaches for Late Onset Pompe

Dwight Koeberl, MD, PhD
Duke University Medical Center

Non-Viral Approaches for Editing Muscle Cells

Jacques Tremblay, PhD
University Laval and CRCHUQ

AAV-delivered Suppressor tRNA

Dan Wang, PhD
UMass Chan Medical School

This session will provide:

• exploration of gene therapy approaches to treat Pompe disease

• discussions on challenges and novel uses of AAV to treat neuromuscular disorders

• insights on how these developments impact the standards and metrics necessary to support clinical translation

Register Now

Dr. Holley is the director of science and education at ASGCT.